FGF2 and ductal breast carcinoma in situ: To verify differences between genes potentially involved in DCIS progression (FGF2, GAS1, and SFRP1) and other 3 DEGs of DCISpure vs DCIScomp (LAMC3, MAP3K8, and IBSP), enrichment was done separately.